Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Open-label Study of ASP2151 in Herpes Simplex Patients
Brief Summary: A multicenter, open-label study is conducted to evaluate the efficacy and safety of ASP2151 in patients with herpes simplex (recurrent labial/facial herpes and recurrent genital herpes and Kaposi varicelliform).